Response to Comments: Homocysteine Level, Serum

This document records administrative actions for the Homocysteine Level, Serum LCD DL34419 (comment period 08/31/2023–10/14/2023; notice period begins 01/25/2024 and becomes effective 03/10/2024). No clinical coverage criteria, limitations, documentation requirements, or frequency limits are provided in this response; it only notes that a provider comment was received.